To evaluate the risks and long-term results of OAGB over a period of 20 years.
SETTING: Tertiary teaching hospital.
METHODS: A total of 2223 patients underwent OAGB from 2001 to 2020; the mean age was 35.3 ± 11.4 years (range, 14-71 yr), 70.2% were female, and the mean body mass index was 40.2 ± 11.9 kg/m2. All data were kept in a prospective bariatric database. Patients were divided into 4 groups, based on the 5-year period in which their surgery was performed, and a retrospective analysis was conducted.
RESULTS: The means for operating time, intraoperative blood loss, and length of
hospital stay after OAGB were 131.9 ± 40.1 minutes, 38.5 ± 30.7 mL, and 4.5 ± 4.0 days, respectively. There were 27 patients (1.2%) with 30-day postoperative major complications overall, but the group rate decreased to .4% in the last 5-year period. At postoperative years 5, 10, and 15, the percentages of total
weight loss were 31.9%, 29.6%, and 29.5%, respectively, and the percentages of excess
weight loss were 77.2%, 68.4%, and 65.5%, respectively. Among 739 patients (33.2%) with
type 2 diabetes (T2D), the rates of complete remission (
glycated hemoglobin < 60%) at 5, 10, and 15 years were 67.3%, 73.8%, and 66.7%, respectively. The
weight loss and antimetabolic effects were similar in each 5-year period, but a significant
malnutrition effect was observed. A total of 113 (5.1%) patients needed
revision surgery at follow-up, due to
malnutrition (n = 51), weight regain (n = 24),
acid or
bile reflux (n = 22),
marginal ulcer (n = 8),
ileus (n = 3), and other causes (n = 5). At 15 years, the overall revision rate was 11.9% (27/226), and 80% of the patients were very satisfied with their procedures.
CONCLUSION: Our results showed that OAGB is a safe and durable primary bariatric procedure, with sustained
weight loss and a high resolution of T2D up to 20 years post surgery in Taiwan, although
malnutrition is a major side effect.